Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,230.00
-10.00 (-0.19%)
At close: Apr 23, 2026

Cellromax Science Revenue

In the year 2025, Cellromax Science had annual revenue of 22.18B KRW with 2.56% growth. Cellromax Science had revenue of 4.48B in the quarter ending December 31, 2025, a decrease of -18.54%.

Revenue
22.18B
Revenue Growth
+2.56%
P/S Ratio
2.60
Revenue / Employee
633.83M
Employees
35
Market Cap
57.74B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202522.18B553.61M2.56%
Dec 31, 202421.63B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition